Form 4: ANI Pharmaceuticals SVP & CFO Sells 7,500 Shares

Stephen P. Carey, SVP & CFO of ANI Pharmaceuticals, sold 7,500 shares of common stock at an average price of $55.79 on December 17, 2024.

Summary

• Stephen P. Carey, the Senior Vice President and Chief Financial Officer of ANI Pharmaceuticals, sold 7,500 shares of the company's common stock on December 17, 2024.
• The sale was executed at a weighted average price of $55.79 per share, with individual trades ranging from $55.29 to $56.30.
• Following the transaction, Mr. Carey directly owns 154,468 shares of ANI Pharmaceuticals common stock.

Sentiment

Score: 5

Explanation: The document is a neutral disclosure of a stock sale by an executive. It doesn't inherently indicate positive or negative sentiment about the company's performance.

Industry Context

This is a routine disclosure of an insider transaction, which is common in the pharmaceutical industry. Such transactions are closely monitored by investors for insights into management's perspective on the company's value.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies in the US, and this transaction is consistent with typical insider trading activity.
• The sale of shares by a high-ranking executive is not unusual, but the market may interpret it as a signal, depending on the context and the volume of shares sold.

Stakeholder Impact

• The sale of shares by a high-ranking executive may be of interest to shareholders, as it could be interpreted as a signal about the executive's confidence in the company's future performance.

Key Dates

Keywords

ANI Pharmaceuticals, Stephen P. Carey, stock sale, insider trading, Form 4, ANIP, CFO